| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.65B | 33.34B | 29.91B | 31.39B | 23.25B | 19.31B |
| Gross Profit | 11.20B | 10.98B | 9.26B | 7.51B | 6.12B | 5.33B |
| EBITDA | 6.89B | 6.86B | 5.42B | 3.81B | 3.34B | 1.85B |
| Net Income | 4.61B | 4.56B | 3.54B | 2.47B | 2.16B | 1.12B |
Balance Sheet | ||||||
| Total Assets | 24.76B | 26.05B | 21.62B | 17.23B | 13.63B | 12.94B |
| Cash, Cash Equivalents and Short-Term Investments | 13.15B | 13.85B | 10.47B | 8.22B | 5.52B | 8.21B |
| Total Debt | 4.33B | 3.69B | 3.76B | 3.16B | 1.62B | 2.16B |
| Total Liabilities | 8.61B | 9.74B | 8.63B | 7.22B | 5.66B | 6.92B |
| Stockholders Equity | 16.16B | 16.31B | 12.99B | 10.01B | 7.97B | 6.02B |
Cash Flow | ||||||
| Free Cash Flow | 1.04B | 4.35B | 3.91B | 814.34M | -905.98M | 2.86B |
| Operating Cash Flow | 1.06B | 4.65B | 4.09B | 1.46B | -619.84M | 2.92B |
| Investing Cash Flow | -131.56M | 3.00M | -1.79B | 80.63M | -1.15B | 375.54M |
| Financing Cash Flow | -580.81M | -1.27B | -52.03M | 1.16B | -924.25M | 733.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥122.20B | 12.17 | ― | 1.22% | -3.37% | 19.40% | |
80 Outperform | ¥68.10B | 10.14 | ― | 3.30% | 10.56% | 27.98% | |
78 Outperform | ¥13.87B | 11.61 | ― | 1.73% | 5.70% | -3.74% | |
74 Outperform | ¥74.27B | 5.57 | ― | 1.79% | -15.80% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
57 Neutral | ¥88.92B | 48.38 | 7.71% | ― | 28.85% | -9.70% |